256 related articles for article (PubMed ID: 37553650)
21. Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate.
Ilie OD; Ciobica A; Doroftei B
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33121072
[No Abstract] [Full Text] [Related]
22. Implementation of stacking based ARIMA model for prediction of Covid-19 cases in India.
Swaraj A; Verma K; Kaur A; Singh G; Kumar A; Melo de Sales L
J Biomed Inform; 2021 Sep; 121():103887. PubMed ID: 34407487
[TBL] [Abstract][Full Text] [Related]
23. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
24. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
25. Vaccine rate forecast for COVID-19 in Africa using hybrid forecasting models.
Dhamodharavadhani S; Rathipriya R
Afr Health Sci; 2023 Mar; 23(1):93-103. PubMed ID: 37545978
[TBL] [Abstract][Full Text] [Related]
26. Forecasting COVID-19 Cases Using Alpha-Sutte Indicator: A Comparison with Autoregressive Integrated Moving Average (ARIMA) Method.
Attanayake AMCH; Perera SSN
Biomed Res Int; 2020; 2020():8850199. PubMed ID: 33344650
[TBL] [Abstract][Full Text] [Related]
27. Prognosticating the Spread of Covid-19 Pandemic Based on Optimal Arima Estimators.
Sandhir V; Kumar V; Kumar V
Endocr Metab Immune Disord Drug Targets; 2021; 21(4):586-591. PubMed ID: 33121426
[TBL] [Abstract][Full Text] [Related]
28. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
[TBL] [Abstract][Full Text] [Related]
29. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
[TBL] [Abstract][Full Text] [Related]
30. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
31. Forecasting daily confirmed COVID-19 cases in Malaysia using ARIMA models.
Singh S; Murali Sundram B; Rajendran K; Boon Law K; Aris T; Ibrahim H; Chandra Dass S; Singh Gill B
J Infect Dev Ctries; 2020 Sep; 14(9):971-976. PubMed ID: 33031083
[TBL] [Abstract][Full Text] [Related]
32. Enhancing COVID-19 Epidemic Forecasting Accuracy by Combining Real-time and Historical Data From Multiple Internet-Based Sources: Analysis of Social Media Data, Online News Articles, and Search Queries.
Li J; Huang W; Sia CL; Chen Z; Wu T; Wang Q
JMIR Public Health Surveill; 2022 Jun; 8(6):e35266. PubMed ID: 35507921
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
34. Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.
Xu S; Li J; Wang H; Wang F; Yin Z; Wang Z
BMC Med; 2023 Apr; 21(1):160. PubMed ID: 37106390
[TBL] [Abstract][Full Text] [Related]
35. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
Wan J; Cazer CL; Clarkberg ME; Henderson SG; Lee SE; Meredith GR; Osman M; Shmoys DB; Frazier PI
PLoS Med; 2023 Jan; 20(1):e1004153. PubMed ID: 36626376
[TBL] [Abstract][Full Text] [Related]
36. Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China.
Li Y; Liu X; Li X; Xue C; Zhang B; Wang Y
BMC Public Health; 2023 Oct; 23(1):2073. PubMed ID: 37872621
[TBL] [Abstract][Full Text] [Related]
37. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
38. Challenges of COVID-19 Case Forecasting in the US, 2020-2021.
Lopez VK; Cramer EY; Pagano R; Drake JM; O'Dea EB; Adee M; Ayer T; Chhatwal J; Dalgic OO; Ladd MA; Linas BP; Mueller PP; Xiao J; Bracher J; Castro Rivadeneira AJ; Gerding A; Gneiting T; Huang Y; Jayawardena D; Kanji AH; Le K; Mühlemann A; Niemi J; Ray EL; Stark A; Wang Y; Wattanachit N; Zorn MW; Pei S; Shaman J; Yamana TK; Tarasewicz SR; Wilson DJ; Baccam S; Gurung H; Stage S; Suchoski B; Gao L; Gu Z; Kim M; Li X; Wang G; Wang L; Wang Y; Yu S; Gardner L; Jindal S; Marshall M; Nixon K; Dent J; Hill AL; Kaminsky J; Lee EC; Lemaitre JC; Lessler J; Smith CP; Truelove S; Kinsey M; Mullany LC; Rainwater-Lovett K; Shin L; Tallaksen K; Wilson S; Karlen D; Castro L; Fairchild G; Michaud I; Osthus D; Bian J; Cao W; Gao Z; Lavista Ferres J; Li C; Liu TY; Xie X; Zhang S; Zheng S; Chinazzi M; Davis JT; Mu K; Pastore Y Piontti A; Vespignani A; Xiong X; Walraven R; Chen J; Gu Q; Wang L; Xu P; Zhang W; Zou D; Gibson GC; Sheldon D; Srivastava A; Adiga A; Hurt B; Kaur G; Lewis B; Marathe M; Peddireddy AS; Porebski P; Venkatramanan S; Wang L; Prasad PV; Walker JW; Webber AE; Slayton RB; Biggerstaff M; Reich NG; Johansson MA
PLoS Comput Biol; 2024 May; 20(5):e1011200. PubMed ID: 38709852
[TBL] [Abstract][Full Text] [Related]
39. Can a combination of vaccination and face mask wearing contain the COVID-19 pandemic?
Brüssow H; Zuber S
Microb Biotechnol; 2022 Mar; 15(3):721-737. PubMed ID: 34962710
[TBL] [Abstract][Full Text] [Related]
40. Application of one-, three-, and seven-day forecasts during early onset on the COVID-19 epidemic dataset using moving average, autoregressive, autoregressive moving average, autoregressive integrated moving average, and naïve forecasting methods.
Lynch CJ; Gore R
Data Brief; 2021 Apr; 35():106759. PubMed ID: 33521186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
